AstraZeneca suspension: We have to act on safety signals, says Glynn

Dr Ronan Glynn said the NIAC felt there was no other choice but to  suspend the rollout of the AstraZeneca vaccine considering the category of people due to receive those vaccines this week.

Deputy Chief Medical Officer (CMO) Dr Ronan Glynn said the National Immunisation Advisory Committee (NIAC) are acting in the best interest of the most vulnerable by pausing the rollout of AstraZeneca vaccines.

Dr Glynn said “everything changed” once public health officials got a notification from the Norwegian Medicines Agency that four new cases of serious blood clotting events in adults occurred in younger people who received the Covid-19 AstraZeneca vaccine.